Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Amgen, academic centers weigh new FDA pilot to speed early drug trials

To better combat China and Australia's dominance in expediting early-phase trials, the FDA and stakeholders are ironing out the details of a pilot program to accelerate first-in-human trials. Amgen, Memorial Sloan Kettering Cancer Center, the ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 25 August →